Loading...

Novo Nordisk Launches Wegovy Pill for Weight Management

By Sofía Garduño - Fri, 01/16/2026 - 10:14

Novo Nordisk launches Wegovy pill in the United States, introducing the first oral GLP-1 option for weight management.

Most popular

https://mexicobusiness.news/tag/glp-1

More Health

The Year in Health: Chronic Diseases, GLP-1s, and AI Adoption

By Sofía Garduño - Tue, 01/13/2026 - 11:20

Healthcare in 2025 reflected a year of adjustment, as chronic disease burden met therapeutic breakthroughs and cautious adoption of AI.

HIV Initiative, GLP-1 Deal, and Coverage Gaps: The Week in Health

By Sofía Garduño - Thu, 12/11/2025 - 18:36

This week, Pfizer formalizes a new GLP-1 partnership, PAHO strengthens HIV elimination efforts, and Mexico prepares to vote on e-cigarette oversight

WHO Issues First Guideline on GLP-1 Therapies for Obesity

By Sofía Garduño - Tue, 12/02/2025 - 14:23

WHO releases its first GLP-1 obesity guideline, outlining conditional use, and a comprehensive approach to chronic disease care.

Oral Semaglutide Falls Short in Alzheimer’s Study: Novo Nordisk

By Sofía Garduño - Mon, 11/24/2025 - 14:24

Novo Nordisk’s phase 3 trials of oral semaglutide in early Alzheimer’s failed to meet primary endpoints.

Eli Lilly Becomes First Drugmaker to Reach US$1 Trillion in Value

By Sofía Garduño - Fri, 11/21/2025 - 12:32

Eli Lilly becomes the first drugmaker to hit US$1 trillion, driven by demand for obesity drugs and expectations for orforglipron’s approval next year.

Eli Lilly Becomes First Drugmaker to Reach US$1 Trillion in Value

By Sofía Garduño - Fri, 11/21/2025 - 11:55

Eli Lilly becomes the first drugmaker to hit US$1 trillion, driven by demand for obesity drugs and expectations for orforglipron’s approval next year.